<VariationArchive VariationID="2032657" VariationName="NM_182894.3(VSX2):c.419del (p.Ala139_Leu140insTer)" VariationType="Deletion" Accession="VCV002032657" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2082875" VariationID="2032657">
      <GeneList>
        <Gene Symbol="VSX2" FullName="visual system homeobox 2" GeneID="338917" HGNC_ID="HGNC:1975" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>14q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="74239449" stop="74262738" display_start="74239449" display_stop="74262738" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="74706174" stop="74729440" display_start="74706174" display_stop="74729440" Strand="+" />
          </Location>
          <OMIM>142993</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_182894.3(VSX2):c.419del (p.Ala139_Leu140insTer)</Name>
      <CanonicalSPDI>NC_000014.9:74241227:TTT:TT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>14q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="74241228" stop="74241228" display_start="74241228" display_stop="74241228" variantLength="1" positionVCF="74241227" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="74707931" stop="74707931" display_start="74707931" display_stop="74707931" variantLength="1" positionVCF="74707930" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.8" sequenceAccession="NC_000014" sequenceVersion="8" change="g.74707933del" Assembly="GRCh37">
            <Expression>NC_000014.8:g.74707933del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.9" sequenceAccession="NC_000014" sequenceVersion="9" change="g.74241230del" Assembly="GRCh38">
            <Expression>NC_000014.9:g.74241230del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_013092.1" sequenceAccession="NG_013092" sequenceVersion="1" change="g.6759del">
            <Expression>NG_013092.1:g.6759del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_129462.1" sequenceAccession="NG_129462" sequenceVersion="1" change="g.531del">
            <Expression>NG_129462.1:g.531del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_182894.3" sequenceAccession="NM_182894" sequenceVersion="3" change="c.419del" MANESelect="true">
            <Expression>NM_182894.3:c.419del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_878314.1" sequenceAccession="NP_878314" sequenceVersion="1" change="p.Ala139_Leu140insTer">
            <Expression>NP_878314.1:p.Ala139_Leu140insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_182894.3(VSX2):c.419del (p.Ala139_Leu140insTer) AND Isolated microphthalmia 2" Accession="RCV002885006" Version="2">
        <ClassifiedConditionList TraitSetID="4106">
          <ClassifiedCondition DB="MedGen" ID="C1864720">Isolated microphthalmia 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-09-26" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20414678</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="4106" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2792" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Isolated microphthalmia 2</ElementValue>
                <XRef ID="MONDO:0012409" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MCOP2</ElementValue>
                <XRef Type="MIM" ID="610093" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">VSX2-Related Isolated Microphthalmia</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">ANOPHTHALMIA, CLINICAL, ISOLATED</Attribute>
                <XRef Type="MIM" ID="610093" DB="OMIM" />
              </AttributeSet>
              <XRef ID="2542" DB="Orphanet" />
              <XRef ID="C1864720" DB="MedGen" />
              <XRef ID="MONDO:0012409" DB="MONDO" />
              <XRef Type="MIM" ID="610093" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5926868" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="17621179|MedGen:C1864720" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003237815" DateUpdated="2024-02-20" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20414678</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with VSX2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Leu140*) in the VSX2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in VSX2 are known to be pathogenic (PMID: 20414678).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="VSX2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000014.8:g.74707931del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1864720" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5926868" TraitType="Disease" MappingType="XRef" MappingValue="C1864720" MappingRef="MedGen">
        <MedGen CUI="C1864720" Name="Isolated microphthalmia 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

